Adagio Medical Holdings, Inc. — Form 8-K
Filed October 1, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Adagio Medical Holdings filed an 8-K on 2026-10-01 reporting an unregistered sale of equity securities (Item 3.02), with period of report 2026-09-25. The filing provides no concrete details: no counterparty name, dollar amount, share count, price per share, or percentage ownership change is disclosed in the accessible text. The actual transaction terms are not specified in this summary document.
Why this rating
Unregistered equity sale is routine disclosure. Micro-cap company (~$7M); lack of specifics prevents full assessment. If material, details would clarify impact.
Extracted items
See more from October 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.